Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN
ATC: M03AX01

Indications

Mesh Heading Maximum Phase Reference
Headache; Post-Traumatic Headache Phase 2 ClinicalTrials
Cicatrix Phase 2 ClinicalTrials
Atrial Fibrillation Phase 2 ClinicalTrials
Osteoarthritis; Osteoarthritis, Knee Phase 1 ClinicalTrials
Dementia Phase 2 ClinicalTrials
Brain Injuries; Brain Injuries, Traumatic Phase 2 ClinicalTrials
Dermatitis; Dermatitis, Seborrheic; Parkinson Disease; Parkinsonian Disorders Phase 1 ClinicalTrials
Syndrome Phase 2/Phase 3 ClinicalTrials
Heart Arrest; Tachycardia; Tachycardia, Ventricular Phase 1 ClinicalTrials
Carpal Tunnel Syndrome; Syndrome Phase 2 ClinicalTrials
Vulvar Diseases; Vulvar Vestibulitis Phase 4 ClinicalTrials
Parkinson Disease Phase 4 ClinicalTrials
Vaginismus Phase 3 ClinicalTrials
Constipation Phase 4 ClinicalTrials
Obesity Phase 1 ClinicalTrials
Cerebral Palsy; Muscle Spasticity Phase 2/Phase 3 ClinicalTrials
Eyelid Diseases Phase 4 ClinicalTrials
CONTENTS